Home Cart Sign in  
Chemical Structure| 134-11-2 Chemical Structure| 134-11-2

Structure of 134-11-2

Chemical Structure| 134-11-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 134-11-2 ]

CAS No. :134-11-2
Formula : C9H10O3
M.W : 166.17
SMILES Code : C1=CC=CC(=C1C(O)=O)OCC
MDL No. :MFCD00002438
InChI Key :XDZMPRGFOOFSBL-UHFFFAOYSA-N
Pubchem ID :67252

Safety of [ 134-11-2 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Computational Chemistry of [ 134-11-2 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 6
Fraction Csp3 0.22
Num. rotatable bonds 3
Num. H-bond acceptors 3.0
Num. H-bond donors 1.0
Molar Refractivity 44.7
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

46.53 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.61
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.96
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.78
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.64
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.55
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.71

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.28
Solubility 0.878 mg/ml ; 0.00528 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.56
Solubility 0.455 mg/ml ; 0.00274 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.29
Solubility 0.842 mg/ml ; 0.00507 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.92 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.56

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.34

Application In Synthesis of [ 134-11-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 134-11-2 ]

[ 134-11-2 ] Synthesis Path-Downstream   1~5

  • 1
  • [ 134-11-2 ]
  • [ 42926-52-3 ]
YieldReaction ConditionsOperation in experiment
With thionyl chloride; for 0.666667h;Heating / reflux; 2-ethoxyl benzoic acid (10.0g, 60.2mmol) was added into thionyl chloride (20ml), and the mixture was refluxed with agitation for 40 minutes, and the excess amount of thionyl chloride was evaporated under reduced pressure. The residual was dissolved into dichloromethane (150ml). Within 30 minutes and being stirred on ice bath, the afore-obtained solution of 2-ethoxyl benzoyl chloride was dropped into the compound (1a) (7.0g, 56.8mmol) dissolved in tetrahydrofuran (80ml) and triethylamine (8.5ml, 61.0mmol). After completion, the mixture was stirred for 1 hour at 0C . After being washed with water and filtrated with diatomaceous earth, the reaction solution was mixed with 20g of silica gel and evaporated to dryness. The resulting residual was eluted with dichloromethane by using silica gel(80g) column to obtain 7.5g of solid product (3a) with the yield of 48%. Furthermore, the sample for analysis was prepared by column chromatography (developing agent: dichloromethane: n-hexane=1:2) and recrystallization (dichloromethane: n-hexane=1:5). mp 183~184C (sublimation 162C); IR (cm-1) : 3326, 3309, 2981, 2938, 2915, 2854, 2208, 1647, 1593, 1471, 1309, 1302, 1232, 1039, 923, 727, 655, 648; 1H NMR (CDCl3) : delta 1.70 (t, J=7.0Hz, 3H), 2.15 (s, 3H), 4.32 (q, J=7.0Hz, 2H), 6.24 (s, 1H), 7.04 (d, 1H), 7.10 (m, 1H), 7.51 (dd, 1H), 8.20 (dd, J=7.9 and 1.8Hz, 1H), 10.69 (brs, 1H), 10.80 (s, 1H); 13CNMR (CDCl3) : delta (CH3) 10.6, 15.0; (CH2) 65.7; (CH) 110.3, 112.3, 121.4 132.1, 134.2; (C) 78.7, 115.6, 119.2, 119.4, 136.7, 157.0, 163.2; MS (ES+) : m/z 287 (M+NH4) . Elemental analysis (C15H15N3O2) : C 66.90%; H 5.61%; N 15.60%; 0 11.88%. The compound (3b) was prepared from compound (1b) according to the above-mentioned method with the yield of 41%. mp 58~61C; IR (cm-1) : 3596, 3336, 2969, 2937, 2877, 2216, 1676, 1658, 1603, 1571, 1537, 1475, 1431, 1292, 1232, 1122, 1037, 927, 789, 752, 577; 1H NMR (CDCl3): delta 0.88 (t, J=7.4Hz, 3H), 1.58 (t, J=7.0Hz, 3H), 1.75(m, 2H), 2.16 (s, 3H), 3.73 (t, J=7.4Hz, 2H),4.30 (q, J=7.0Hz, 2H), 6.36 (s, 1H), 7.04 (d, 1H), 7.11 (m, 1H), 7.48 (dd, 1H), 8.23 (dd, J=7.9 and 1.8Hz, 1H), 9.62 (brs, 1H) ; 13C NMR (CDCl3) : delta (CH3) 11.1, 14.8; (CH2) 23.6, 48.3, 65.2; (CH) 112.5, 117.0, 121.3, 132.5, 134.1; (C) 89.2, 115.6, 119.8, 120.5, 131.2, 157.1, 165.0; MS (ES+): m/z 329 (M+NH4).
With thionyl chloride;N,N-dimethyl-formamide; In hexane; for 1h;Heating / reflux; To a stirred solution of 2-Ethoxy-6-pentadecylbenzoic Acid (6.5 g, 16 mmol) in hexane (60 mL) were added thionyl chloride (2.5 g, 21 mmol) and N,N-dimethylformamide (0.5 mL). The reaction mixture was heated to reflux for 1 h. After the reaction was complete, the solvent was evaporated under reduced pressure to yield the desired 2-Ethoxy-benzoyl Chloride, which was redissolved in dichloromethane (50 mL) and used for the condensation with anilides.
With oxalyl dichloride;N,N-dimethyl-formamide; In dichloromethane; at 0 - 20℃; for 1h; Example 9A 2-ethoxy-N-(4-trifluoromethyl-thiazol-2-yl)-benzamide A solution of 2-ethoxybenzoic acid (0.75 g, 4.5 mmol) in 23 mL of methylene chloride at 0 C. was treated with oxalyl chloride (0.44 mL, 4.9 mmol) followed by 2 drops of dimethylformamide. The solution was stirred at ambient temperature for 1 hour and then concentrated under reduced pressure to provide 0.83 g of 2-ethoxybenzoyl chloride.
With oxalyl dichloride;N,N-dimethyl-formamide; In dichloromethane; at 0 - 20℃; for 1h; A solution of 2-ethoxybenzoic acid (0.75 g, 4.5 mmol) in 23 mL of methylene chloride at 0 0C was treated with oxalyl chloride (0.44 mL, 4.9 mmol) followed by 2 drops of dimethylformamide. The solution was stirred at ambient temperature for 1 hour and then concentrated under reduced pressure to provide 0.83 g of 2-ethoxybenzoyl chloride
With 1-methyl-pyrrolidin-2-one; thionyl chloride; In ethyl acetate; for 1h;Reflux; Compound (16a) (10.0 g, 29.9 mmol) was added to AcOEt (100 ml), and then triethylamine (15.1 ml, 3.6 eq. ) was added thereto, followed by stirring at room temperature for one hour. The solution was cooled to about 0C. Separately, N- methylpyrrolidone (200 mu) and AcOEt (50 ml) were added to 2- ethoxybenzoic acid (5.95 g, 1.2 eq.), and then thionyl chloride (2.83 ml, 1.3 eq. ) was added thereto, followed by heating at reflux for one hour to prepare a solution of 2-ethoxybenzoyl chloride. The solution of 2-ethoxybenzoyl chloride was added at 0C to the Compound (16a) -containing solution, which had been obtained as above, followed by striing at the same temperature for 30 minutes. After the completion of the reaction, water (50 ml) and concentrated hydrochloric acid (5 ml) were added thereto, and extraction and liquid separation was performed. Subsequently, the organic layer was washed with water (50 ml) and a 25% NaOH aqueous solution (5 ml), and concentrated to dryness to obtain an oily product. EtOH (50 ml) and water (20 ml) were added to the oily product, followed by dissolution, and a seed crystal was added thereto, followed by cooling and aging. The precipitated crystals were then collected by filtration, and dried at 45C to give Compound (1a) (9.70 g) . Compound (1a): 1H NMR (CDCl3, 400 MHz) delta 1.40 (d, J = 6.0 Hz, 6H) , 1.49 (t, J = 6.9 Hz, 3H), 4.19 (q, J = 6.9 Hz, 2H) , 4.63 (d, J = 5.5 Hz, 2H) 4.69 (sept, J = 6.0 Hz, 1H) , 6.63 (t, J = 75 Hz, 1H) , 6.95 (d, J = 8.2 Hz, 1H), 7.08 (t, J = 7.8 Hz, 1H) , 7.23 (d, J = 8.2 Hz 1H) , 7.43 (td, J = 8.0, 1.4 Hz, 1H),7.59 (dd, J = 8.2, 1.8 Hz, 1H) 7.67 (d, J = 1.8 Hz, 1H) , 7.67 (s, 1H) , 8.24 (dd, J = 7.8, 1.8 Hz, 1H), 8.56 (br-s, 1H).
With thionyl chloride; N,N-dimethyl-formamide; at 20℃; for 24h; General procedure: Benzo[d][1,3]dioxole-5-carboxylic acid (8.00 g, 48.1 mmol), SOCl2 (10.4 mL, 144 mmol) and DMF (0.15 mL, 2 mmol) were mixed together in a flask protected with CaCl2 trap and stirred magnetically at r.t. After 24 h, the homogeneous mixture was diluted with toluene (100 mL) and concentrated on a rotary evaporator at 40 C; the residue was diluted with CHCl3 (20 mL) at -10 C and added dropwise to stirred aqueous ammonia (25%, 30 mL) at -10 C. The layers were separated, the aqueous layer was extracted with CHCl3 (2 × 25 mL) and the combined organic extracts were concentrated on a rotary evaporator at 20-80 C. The residue was used without further purification.
With thionyl chloride; In dichloromethane; at 100℃; for 0.5h;Cooling with ice; 1) Preparation of 2-ethoxybenzoyl chloride: lm0l 2-ethoxybenzoic acid was dissolved in methylene chloride to give 2-ethoxybenzoyl chloride at a concentration of lOOOmI / L , Ice bath conditions slowly dropping l.lmol thionyl chloride, drop after completion, 100 C refluxing reaction for 30 minutes, vacuum distillation to remove dichloromethane, 2-ethoxy benzoyl chloride, without further purification , Direct follow-up reaction;

  • 2
  • [ 6609-57-0 ]
  • [ 938-73-8 ]
  • [ 134-11-2 ]
  • 3
  • [ 6609-57-0 ]
  • alcoholic potash [ No CAS ]
  • [ 938-73-8 ]
  • [ 134-11-2 ]
  • 5
  • [ 7499-07-2 ]
  • [ 134-11-2 ]
  • [ 54109-03-4 ]
  • 3,3'-dichloro-5,5'-dimethyl-1,1'-biphenyl [ No CAS ]
  • 3,3'-diethoxy-1,1'-biphenyl [ No CAS ]
  • 3-chloro-3'-ethoxy-5-methyl-1,1'-biphenyl [ No CAS ]
 

Historical Records

Technical Information

Categories